PEG-IFN-α-2a therapy in patients with myelofibrosis

被引：47
|
作者：
Ianotto, Jean-Christophe [1 ]
Kiladjian, Jean-Jacques [2 ]
Demory, Jean-Louis [3 ]
Roy, Lydia [4 ]
Boyer, Francoise [5 ]
Rey, Jerome [6 ]
Dupriez, Brigitte [7 ]
Berthou, Christian [1 ]
Abgrall, Jean-Francois [8 ]
机构：
[1] Hop Morvan, CHU, Inst Canc Hematol, Serv Hematol Clin, Brest, France
[2] AP HP, Serv Hematol Clin, Bobigny, France
[3] Hop St Vincent, Dept Hematol, Lille, France
[4] CHU La Miletrie, Dept Oncohematol & Therapie Cellulaire, Poitiers, France
[5] CHU Angers, Serv Malad Sang, Angers, France
[6] Inst J Paoli I Calmettes, Dept Oncohematol, F-13009 Marseille, France
[7] CH, Serv Hematol Clin, Lens, France
[8] CHU Brest, Hop Cavale Blanche, Hematol Lab, F-29285 Brest, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2009年 / 146卷 / 02期
关键词：
myelofibrosis; treatment; pegylated-interferon; response criteria; European Myelofibrosis Network; MYELOID METAPLASIA; POLYCYTHEMIA-VERA; INTERFERON; CRITERIA;
D O I：
10.1111/j.1365-2141.2009.07745.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 225
页数：3
相关论文
共 50 条
  • [41] Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients
    Wang, Wen-Xin
    Jia, Rui
    Jin, Xue-Yuan
    Li, Xiaoyan
    Zhou, Shuang-Nan
    Zhang, Xiao-Ning
    Zhou, Chun-Bao
    Wang, Fu-Sheng
    Fu, Junliang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] PEG-IFNα-2a与PEG-IFNα-2b治疗慢性乙型肝炎患者疗效研究
    林金祥
    杨可立
    实用肝脏病杂志, 2021, 24 (01) : 27 - 30
  • [43] Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin
    Fujino, Tatsuya
    Nakamuta, Makoto
    Aoyagi, Yoko
    Kohjima, Motoyuki
    Satoh, Takeaki
    Fukuda, Mika
    Ishibashi, Hiromi
    Yatsuhashi, Hiroshi
    Enjoji, Munechika
    MEDICAL SCIENCE MONITOR, 2011, 17 (12): : CR687 - CR691
  • [44] African-american patients with chronic hepatitis c respond similarly to PEG-IFN alpha 2a and ribavirin as compared to PEG-IFN alpha 2b and ribavirin
    Khan, Afreen
    Mutchnick, Milton
    Ehrinpreis, Murray
    Siddiqui, Firdous
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S124 - S124
  • [45] 肝功能正常的CHB患者应用Peg-IFN-α 2a抗病毒治疗致HBsAg低于检测下限1例
    高朋彬
    路遥
    申戈
    吴淑玲
    常敏
    吴云忠
    张璐
    李明慧
    谢尧
    中国肝脏病杂志(电子版), 2014, 6 (03) : 77 - 79
  • [46] Early prediction of response to Peg-IFNα-2a or Peg-IFNα-2b plus ribavirin in the single chronic hepatitis C patients by modeling the dynamics of infected cells
    Ciccorossi, P.
    Colombatto, P.
    Maina, A.
    Civitano, L.
    Oliveri, F.
    Sacco, R.
    Coco, B.
    Bonino, F.
    Brunetto, M.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S26 - S27
  • [47] Peg-IFN-α2a联合肝复乐胶囊对HbeAg阳性慢性乙型肝炎抗肝纤维化的疗效
    张继万
    周建丽
    张晓芳
    隆莉
    吴刚
    武警医学, 2017, 28 (03) : 257 - 260
  • [48] Combination therapy with PEG-IFN-α and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53
    S Hagiwara
    M Kudo
    T Nakatani
    Y Sakaguchi
    M Nagashima
    N Fukuta
    M Kimura
    S Hayakawa
    H Munakata
    British Journal of Cancer, 2007, 97 : 1532 - 1537
  • [49] Genetic Variation in Interleukin-28B and Response to Peg-IFNα-2a/RBV Combination Therapy in Patients with Hepatitis C Virus Infection
    Bokharaei-Salim, Farah
    Salehi-Vaziri, Mostafa
    Sadeghi, Farzin
    Khanaliha, Khadijeh
    Esghaei, Maryam
    Monavari, Seyed Hamidreza
    Alavian, Seyed Moayed
    Fakhim, Shahin
    Keyvani, Hossein
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2017, 10 (01)
  • [50] PHARMACOKINETICS OF PEG-INTERFERON LAMBDA (PEG-IFN-λ) FOLLOWING FIXED DOSING IN TREATMENT-NAiVE HEPATITIS C SUBJECTS (SINGLE DOSE INTERIM DATA FROM A DOSE-RANGING PHASE 2A STUDY)
    Byrnes-Blake, Kelly A.
    Freeman, Jeremy A.
    Rapalus, Lisa
    Pederson, Susan
    Fontana, David
    Lopez-Talavera, Juan Carlos
    Kansra, Vikram
    Miller, Dennis M.
    HEPATOLOGY, 2010, 52 (04) : 720A - 721A
12345